$549 Million is the total value of GREAT POINT PARTNERS LLC's 42 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 70.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| URGN | New | UROGEN PHARMA LTD | $36,713,835 | – | 2,620,545 | +100.0% | 6.69% | – |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $35,250,348 | +1.9% | 3,078,633 | -8.5% | 6.42% | -5.2% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $30,434,891 | +8.4% | 1,755,184 | +13.2% | 5.54% | +0.8% |
| PCVX | Sell | VAXCYTE INC | $27,081,137 | -8.0% | 531,211 | -9.8% | 4.93% | -14.4% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $25,932,737 | -17.0% | 727,426 | +7.4% | 4.72% | -22.8% |
| ALKS | Buy | ALKERMES PLC | $24,509,982 | +90.3% | 875,044 | +112.7% | 4.46% | +77.1% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $24,233,123 | -11.6% | 1,458,070 | -0.5% | 4.41% | -17.7% |
| ZURA BIO LTD | $21,747,000 | -19.5% | 3,295,000 | 0.0% | 3.96% | -25.1% | ||
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $20,025,544 | +41.5% | 165,200 | +33.7% | 3.65% | +31.6% |
| EOLS | Sell | EVOLUS INC | $19,988,577 | +13.0% | 2,186,934 | -10.2% | 3.64% | +5.1% |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $19,409,433 | -28.6% | 2,909,960 | -3.0% | 3.54% | -33.6% |
| CYTK | CYTOKINETICS INC | $17,676,000 | -9.7% | 600,000 | 0.0% | 3.22% | -16.0% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $17,080,034 | -16.3% | 500,001 | -5.7% | 3.11% | -22.1% |
| ANAB | ANAPTYSBIO INC | $16,062,221 | -11.7% | 894,333 | 0.0% | 2.93% | -17.8% | |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $15,098,592 | -15.2% | 290,917 | -2.1% | 2.75% | -21.1% |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $14,808,032 | -7.4% | 1,091,233 | +17.1% | 2.70% | -13.8% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $11,720,250 | – | 225,000 | +100.0% | 2.14% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $11,588,611 | -42.4% | 1,691,768 | -12.9% | 2.11% | -46.4% |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $11,515,900 | – | 95,000 | +100.0% | 2.10% | – |
| PTCT | New | PTC THERAPEUTICS INC | $11,205,000 | – | 500,000 | +100.0% | 2.04% | – |
| REPL | New | REPLIMUNE GROUP INC | $10,924,649 | – | 638,495 | +100.0% | 1.99% | – |
| OPTN | OPTINOSE INC | $10,873,125 | 0.0% | 8,839,939 | 0.0% | 1.98% | -7.0% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $10,421,120 | +18.3% | 857,000 | +22.2% | 1.90% | +10.0% |
| Buy | ARCELLX INC | $10,315,500 | +770.0% | 287,500 | +666.7% | 1.88% | +709.9% | |
| KRTX | New | KARUNA THERAPEUTICS INC | $10,229,945 | – | 60,500 | +100.0% | 1.86% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $10,040,130 | – | 198,500 | +100.0% | 1.83% | – |
| INSM | New | INSMED INC | $9,970,518 | – | 394,872 | +100.0% | 1.82% | – |
| RPHM | Buy | RENEO PHARMACEUTICALS INC | $8,887,170 | +25.1% | 1,167,061 | +7.7% | 1.62% | +16.4% |
| New | APOGEE THERAPEUTICS INC | $8,520,000 | – | 400,000 | +100.0% | 1.55% | – | |
| GOSS | New | GOSSAMER BIO INC | $5,188,571 | – | 6,230,272 | +100.0% | 0.94% | – |
| IGMS | Buy | IGM BIOSCIENCES INC | $5,137,897 | +11.3% | 615,317 | +23.1% | 0.94% | +3.7% |
| HRTX | HERON THERAPEUTICS INC | $4,879,489 | -11.2% | 4,737,368 | 0.0% | 0.89% | -17.4% | |
| ACRS | New | ACLARIS THERAPEUTICS INCcall | $4,795,000 | – | 700,000 | +100.0% | 0.87% | – |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $4,693,450 | – | 215,000 | +100.0% | 0.86% | – |
| ABOS | Buy | ACUMEN PHARMACEUTICALS INC | $4,457,519 | -11.8% | 1,074,101 | +2.2% | 0.81% | -18.0% |
| GBIO | GENERATION BIO CO | $3,875,415 | -31.1% | 1,022,537 | 0.0% | 0.71% | -35.9% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $3,759,315 | – | 86,302 | +100.0% | 0.68% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $3,248,872 | – | 645,899 | +100.0% | 0.59% | – |
| TALS | Buy | TALARIS THERAPEUTICS INC | $2,810,000 | +38.8% | 1,000,000 | +50.1% | 0.51% | +29.3% |
| GRCL | Sell | GRACELL BIOTECHNOLOGIES INCsponsored ads | $1,669,441 | -80.7% | 579,667 | -74.4% | 0.30% | -82.0% |
| Sell | SOLID BIOSCIENCES INC | $1,135,016 | -62.9% | 450,403 | -22.9% | 0.21% | -65.5% | |
| AMAM | New | AMBRX BIOPHARMA INCcall | $1,123,550 | – | 97,700 | +100.0% | 0.20% | – |
| XENE | Exit | XENON PHARMACEUTICALS INCput | $0 | – | -2,700 | -100.0% | -0.02% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INCcall | $0 | – | -70,000 | -100.0% | -0.04% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.18% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INCput | $0 | – | -255,000 | -100.0% | -0.52% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -7,469,736 | -100.0% | -0.77% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -938,067 | -100.0% | -0.88% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -350,000 | -100.0% | -1.24% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -601,322 | -100.0% | -1.30% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCput | $0 | – | -94,700 | -100.0% | -1.69% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -546,059 | -100.0% | -1.82% | – | |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -598,550 | -100.0% | -1.90% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -772,000 | -100.0% | -2.49% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -968,795 | -100.0% | -4.09% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.